Banco de Sabadell shareholders approved reelecting Chief Executive Cesar Gonzalez-Bueno Mayer as executive director, as the ...

SAB Biotherapeutics (SABS) held cash and equivalents of $20.8 million at December 31, 2024, compared to $56.6 million at December 31, 2023.

SAB-142 Phase 1 trial positive topline data announced at KOL eventMIAMI, March 31, 2025 (GLOBE NEWSWIRE) -- SAB BIO (Nasdaq: ...

Wal-Mart de Mexico SAB, the local unit of the US retail giant, plans to invest $6 billion this year in its Mexico operations ...

The beer giant's initiative to clear invasive plants in the Western Cape has restored billions of litres of water, boosting ...

Regulatory shifts, including dropped SEC lawsuits and the repeal of SAB 121, are paving the way for greater crypto adoption by traditional financial institutions, says ABC Labs CEO Thomas Mattimore.

Samuel J. Reich, Chairman and CEO of SAB BIO stated, “Our recent announcement of positive topline data for SAB-142, further strengthens our belief that SAB-142 has the potential to be the best ...